Article Details
Retrieved on: 2021-08-16 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The latest round was co-led by OrbiMed with participation from Sino Biopharma and existing investors Sequoia Capital China and 5Y Capital, ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here